UNSPSC 51343821: Lopinavir/ritonavir

Definition: This classification denotes a combination drug for treatment of HIV. The first component, LOPINAVIR is a protease inhibitor with a US FDA Unique Ingredient Identifier of 2494G1JF75. LOPINAVIR is an International Non-Proprietary Name or INN. The second component, RITONAVIR, is a pharmacokinetic booster with a US FDA Unique Ingredient Identifier of O3J8G9O825. RITONAVIR is an International Non-Proprietary Name or INN.

UNSPSC 51343821 Lopinavir/ritonavir is a Commodity code nominally covering a specific antiretroviral pharmaceutical, but recent state and local opportunities show minimal activity actually aligned with this product. The code appears in the procurement dataset primarily because Dane County used it to tag a broader pharmaceutical services RFP for long-term care facility drug distribution, not because lopinavir/ritonavir itself is a focus of current solicitation activity. A review of recent opportunities reveals one relevant procurement (Dane County's RFP 2026RFP061PR for Badger Prairie Health Care Center pharmaceutical services, due October 22, 2026) and multiple unrelated opportunities tagged with this code—including Collier County's notice of intent to single-source a pediatric EMS drug-dosage calculation app (Handtevy), Washington County Oregon's naloxone distribution center letter of interest, District of Columbia pharmacy benefits network qualification request, Tucson Fire Department's BLS/ALS pharmaceuticals and vending machine RFP, West Texas Centers' prescription services RFP, and Seminole County's naloxone and drug deactivation systems IFB. These latter opportunities concern emergency medical supplies, behavioral health pharmaceuticals, opioid-reversal products, and pharmacy network administration—none of which are lopinavir/ritonavir procurement.

Dane County is the only issuing body pursuing pharmaceutical services under this code in the recent dataset; the county's RFP emphasizes daily medication delivery, barcode-enabled inventory management, secure portal prescription communication, and integration with the facility's electronic patient care reporting system, with contract value currently budgeted at $125,000 annually. The RFP applies a local-vendor preference (five bonus evaluation points for Dane County vendors, two for adjacent counties) and runs January 1, 2027 through December 31, 2031. The remaining tagged opportunities represent a systematic miscoding issue: this Commodity code does not meaningfully capture the current state and local purchasing activity in its nominal product category. Firms pursuing lopinavir/ritonavir sales should monitor broader pharmaceutical distribution and long-term care facility procurement vehicles; this specific code presently shows limited decision-relevant activity.